Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS
Abstract
We have previously reported the copper binding properties of R3 peptide (residues 318-335: VTSKCGSLGNIHHKPGGG, according to the longest tau protein) derived from the third repeat microtubule-binding domain of water-soluble tau protein. In this work, we have investigated copper binding properties of R2 peptide (residues 287-304: VQSKCGSKDNIKHVPGGG) derived from the second repeat region of tau protein. Similar to R3 peptide, R2 peptide also plays an important role in the formation of neurofibrillary tangles (NFTs) which is one of the two main biological characteristics of Alzheimer's disease (AD). Based on the copper binding properties of R2 peptide, the possible influences of the binding on the formation of NFTs were investigated. Results from circular dichroism (CD) spectra, nuclear magnetic resonance (NMR) spectroscopy, and matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) suggest that the binding is pH-dependent and stoichiometry-determined. In addition, these results also reveal that R2 peptide adopts a monomeric alpha-helical structure in aqueous solutions at physiological pH after the addition of 1 mol equiv. of Cu2+. Since alpha-helix structure is responsible for the formation of paired helical filaments (PHFs) which aggregate into NFTs, it is hypothesized that Cu2+ induces R2 peptide to self-assemble into a PHFs-like structure. Hence, it is postulated that Cu2+ plays an important role in the aggregation of R2 peptide and tau protein and that copper binding to R2 peptide may be another possible involvement in AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Copper can bind to tau in vitro and enhance tau phosphorylation by activating CDK5/P25 in AD transgenic mice.
“Copper can bind to tau in vitro [542, 543], and enhance tau phosphorylation by activating CDK5/P25 in AD transgenic mice (APPswe, PS1, P301Ltau) [544, 545].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [542]
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780 · see citing works
Sigel, H., & Martin, R. B. (1982) · Chemical Reviews · doi:10.1021/cr00050a003 · Cited by 1,613 · see citing works
Sundberg, R. J., & Martin, R. B. (1974) · Chemical Reviews · doi:10.1021/cr60290a003 · Cited by 1,147 · see citing works
Role of tau protein in both physiological and pathological conditions
AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works
The Primary Structure and Heterogeneity of Tau Protein from Mouse Brain
Lee, G. S., Cowan, N. J., & Kirschner, M. W. (1988) · Science · doi:10.1126/science.3122323 · Cited by 680 · see citing works
Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer's Disease
Syme, C. D., Nadal, R. C., Rigby, S. E. J., & Viles, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313572200 · Cited by 459 · see citing works
Metal Binding Modes of Alzheimer's Amyloid β-Peptide in Insoluble Aggregates and Soluble Complexes
Miura, T., Suzuki, K., Kohata, N., & Takeuchi, H. (2000) · Biochemistry · doi:10.1021/bi0002479 · Cited by 452 · see citing works
Schweers, O., Mandelkow, E., Biernat, J., & Mandelkow, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8463 · Cited by 379 · see citing works
Berriman, J. A., Serpell, L. C., Oberg, K. A., Fink, A. L., Goedert, M., & Crowther, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530287100 · Cited by 288 · see citing works
Effect of Chain Length on the Formation and Stability of Synthetic .alpha.-Helical Coiled Coils
Su, J. Y., Hodges, R. S., & Kay, C. M. (1994) · Biochemistry · doi:10.1021/bi00255a032 · Cited by 245 · see citing works
Jones, C. E., Abdelraheim, S. R., Brown, D. R., & Viles, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403467200 · Cited by 227 · see citing works
Barghorn, S., Davies, P., & Mandelkow�, E. (2004) · Biochemistry · doi:10.1021/bi0357006 · Cited by 209 · see citing works
Charge-transfer absorptions of copper(II)-imidazole and copper(II)-imidazolate chromophores
Fawcett, T. G., Bernarducci, E. E., Krogh‐Jespersen, K., & Schugar, H. J. (1980) · Journal of the American Chemical Society · doi:10.1021/ja00528a013 · Cited by 189 · see citing works
Triggers of Full-Length Tau Aggregation: A Role for Partially Folded Intermediates
Chirita, C. N., Congdon, E. E., Yin, H., & Kuret, J. (2005) · Biochemistry · doi:10.1021/bi0500123 · Cited by 166 · see citing works
Visible circular dichroism of copper(II) complexes of amino acids and peptides
Tsangaris, J. M., & Martin, R. B. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00717a020 · Cited by 119 · see citing works
α-Helix Structure in Alzheimer's Disease Aggregates of Tau-Protein
Sadqi, M., Hernández, F., Pan, U., Pérez, M., Schaeberle, M. D., Ávila, J., & Muñoz, V. (2002) · Biochemistry · doi:10.1021/bi025777e · Cited by 117 · see citing works
Ultraviolet circular dichroism of cupric and nickel ion complexes of amino acids and peptides
Tsangaris, J. M., Chang, J. W., & Martin, R. B. (1969) · Journal of the American Chemical Society · doi:10.1021/ja01031a038 · Cited by 101 · see citing works
Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI‐TOF MS, CD, and NMR
Ma, Q., Li, Y., Du, J., Kanazawa, K., Nemoto, T., Nakanishi, H., & Zhao, Y. (2005) · Biopolymers · doi:10.1002/bip.20335 · Cited by 96 · see citing works
Self-citationBryce, G. F., & Gurd, F. R. N. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96792-x · Cited by 57 · see citing works
Role for the α-Helix in Aberrant Protein Aggregation
Kunjithapatham, R., Oliva, F. Y., Doshi, U., Pérez, M., Ávila, J., & Muñoz, V. (2004) · Biochemistry · doi:10.1021/bi048564t · Cited by 54 · see citing works
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
Torreilles, F., & Touchon, J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00030-2 · Cited by 37 · see citing works
Ma, K., & Wang, K. (2003) · Biopolymers · doi:10.1002/bip.10477 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works
Self-citationNeurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219 · see citing works
Metal ions, Alzheimer's disease and chelation therapy
Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202 · see citing works
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease
Brewer, G. J. (2012) · BioFactors · doi:10.1002/biof.1005 · Cited by 188 · see citing works
Kanti Das, T., Wati, M. R., & Fatima-Shad, K. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.20078 · Cited by 177 · see citing works
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146 · see citing works
Yan, L., Guo, M.-S., Zhang, Y., Yu, L., Wu, J.-M., Tang, Y., Ai, W., Zhu, F.-D., Law, B. Y.-K., Chen, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5288698 · Cited by 97 · see citing works
Modulation of tau phosphorylation by environmental copper
Voss, K., Harris, C., Ralle, M., Duffy, M., Murchison, C., & Quinn, J. F. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-24 · Cited by 83 · see citing works
Probing copper/tau protein interactions electrochemically
Martic, S., Rains, M. K., & Kraatz, H.-B. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.07.015 · Cited by 60 · see citing works
- Authors
- Ma, Q., Li, Y., Du, J., Liu, H., Kanazawa, K., Nemoto, T., Nakanishi, H., & Zhao, Y.
- Affiliations
- Tsinghua University (CN)
- National Institute of Advanced Industrial Science and Technology (JP)
- Corresponding author
- Li, Yanmei
- Venue
- Peptides
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 27
- Issue
- 4
- Pages
- 841-849
- ISSN
- 0196-9781 (ISSN-L)
- OpenAlex
- W2046997729
- Cited by
- 123
- References
- 23
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 11 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 10 · 2013: 4 · 2012: 8
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Peptides (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- tau protein, copper binding, Alzheimer's disease, neurofibrillary tangles, paired helical filaments, alpha-helix, pH-dependent binding, stoichiometry, microtubule-binding domain
- MeSH terms
- Alzheimer Disease, Circular Dichroism, Copper, Humans, Models, Molecular, Peptide Fragments, Protein Binding, Protein Conformation, tau Proteins, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Nuclear Magnetic Resonance, Biomolecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
